Atomic Force Microscope Nanoindentation Analysis of Diffuse Astrocytic Tumor Elasticity: Relation with Tumor Histopathology
- PMID: 34572766
- PMCID: PMC8465072
- DOI: 10.3390/cancers13184539
Atomic Force Microscope Nanoindentation Analysis of Diffuse Astrocytic Tumor Elasticity: Relation with Tumor Histopathology
Abstract
This study aims to investigate the influence of isocitrate dehydrogenase gene family (IDH) mutations, World Health Organization (WHO) grade, and mechanical preconditioning on glioma and adjacent brain elasticity through standard monotonic and repetitive atomic force microscope (AFM) nanoindentation. The elastic modulus was measured ex vivo on fresh tissue specimens acquired during craniotomy from the tumor and the peritumoral white matter of 16 diffuse glioma patients. Linear mixed-effects models examined the impact of tumor traits and preconditioning on tissue elasticity. Tissues from IDH-mutant cases were stiffer than those from IDH-wildtype ones among anaplastic astrocytoma patients (p = 0.0496) but of similar elasticity to IDH-wildtype cases for diffuse astrocytoma patients (p = 0.480). The tumor was found to be non-significantly softer than white matter in anaplastic astrocytomas (p = 0.070), but of similar elasticity to adjacent brain in diffuse astrocytomas (p = 0.492) and glioblastomas (p = 0.593). During repetitive indentation, both tumor (p = 0.002) and white matter (p = 0.003) showed initial stiffening followed by softening. Stiffening was fully reversed in white matter (p = 0.942) and partially reversed in tumor (p = 0.015). Tissue elasticity comprises a phenotypic characteristic closely related to glioma histopathology. Heterogeneity between patients should be further explored.
Keywords: IDH; WHO grade; atomic force microscopy; diffuse glioma; elastic modulus; tissue mechanics.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Estimation of the occurrence rates of IDH1 and IDH2 mutations in gliomas and the reconsideration of IDH-wildtype anaplastic astrocytomas: an institutional experience.J Int Med Res. 2021 Jun;49(6):3000605211019258. doi: 10.1177/03000605211019258. J Int Med Res. 2021. PMID: 34162262 Free PMC article.
-
Clinical significance of the 2016 WHO classification in Japanese patients with gliomas.Brain Tumor Pathol. 2018 Apr;35(2):71-80. doi: 10.1007/s10014-018-0309-0. Epub 2018 Feb 22. Brain Tumor Pathol. 2018. PMID: 29470683
-
[Mutation of isocitrate dehydrogenase gene in Chinese patients with glioma].Zhonghua Bing Li Xue Za Zhi. 2013 May;42(5):292-8. doi: 10.3760/cma.j.issn.0529-5807.2013.05.002. Zhonghua Bing Li Xue Za Zhi. 2013. PMID: 24004584 Chinese.
-
Diffuse astrocytic glioma, IDH-Wildtype, with molecular features of glioblastoma, WHO grade IV: A single-institution case series and review.J Neurooncol. 2021 Mar;152(1):89-98. doi: 10.1007/s11060-020-03677-4. Epub 2021 Jan 3. J Neurooncol. 2021. PMID: 33389563 Review.
-
IDH mutations in older patients with diffuse astrocytic gliomas.Ann Diagn Pathol. 2020 Dec;49:151653. doi: 10.1016/j.anndiagpath.2020.151653. Epub 2020 Oct 25. Ann Diagn Pathol. 2020. PMID: 33137656 Review.
Cited by
-
Universal Markers Unveil Metastatic Cancerous Cross-Sections at Nanoscale.Cancers (Basel). 2022 Jul 31;14(15):3728. doi: 10.3390/cancers14153728. Cancers (Basel). 2022. PMID: 35954392 Free PMC article.
-
Nanomechanical and Morphological AFM Mapping of Normal Tissues and Tumors on Live Brain Slices Using Specially Designed Embedding Matrix and Laser-Shaped Cantilevers.Biomedicines. 2022 Jul 19;10(7):1742. doi: 10.3390/biomedicines10071742. Biomedicines. 2022. PMID: 35885046 Free PMC article.
-
Influence of MMR, MGMT Promotor Methylation and Protein Expression on Overall and Progression-Free Survival in Primary Glioblastoma Patients Treated with Temozolomide.Int J Mol Sci. 2023 Mar 24;24(7):6184. doi: 10.3390/ijms24076184. Int J Mol Sci. 2023. PMID: 37047153 Free PMC article.
References
-
- Nakada M., Kita D., Futami K., Yamashita J., Fujimoto N., Sato H., Okada Y. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma. J. Neurosurg. 2001;94:464–473. doi: 10.3171/jns.2001.94.3.0464. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous